Most studies in mouse models suggest that the ATX-LPA-LPA receptor axis contributes to the obesity-related impairment of glucose homeostasis, insulin resistance, inflammation, mitochondrial dysfunction, tissue fibrosis, hepatic steatosis, and cardiomyopathy. This evidence concerns the gene INS and fatty liver disease.